BACKGROUND: Endothelium-derived nitric oxide plays a crucial role in the regulation of vascular tone and the development of cardiovascular disease. The endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) has emerged as a novel cardiovascular risk factor. ADMA appears to be an independent predictor for cardiovascular and overall mortality. However, the majority of studies investigating the clinical role of ADMA were performed in European study populations with few individuals of other ethnicities.
Endothelium-derived nitric oxide plays a crucial role in the regulation of vascular tone, platelet activity, leukocyte adhesion, and the development of arteriosclerosis (1 ) . All known risk factors for arteriosclerosis, i.e., hypercholesterolemia, diabetes, hypertension, and chronic smoking, are associated with endothelial dysfunction secondary to reduced vascular nitric oxide bioavailability.
Asymmetric dimethylarginine (ADMA) 8 has emerged over the past decade as a novel cardiovascular risk factor. ADMA is derived from proteins that have been posttranslationally methylated and subsequently hydrolyzed to release free ADMA. ADMA is secreted into body fluids and excreted into the urine. The major pathway for elimination of ADMA is its metabolism by the enzyme dimethylarginine dimethylaminohydrolase, yielding L-citrulline and dimethylamine (2 ) . A minor portion of circulating ADMA is excreted directly via the kidneys. Vallance et al. demonstrated in 1992 (3 ) that ADMA plasma concentrations are increased in patients with renal insufficiency. Increased ADMA plasma concentrations have been demonstrated in patients with hypertension, hyperlipidemia, coronary artery disease, peripheral arterial occlusive disease, congestive heart failure, stroke, pulmonary hypertension, and end-stage renal disease, among others (4 ). Moreover, ADMA appears to be an independent predictor of acute coronary events, subsequent adverse cardiovascular events after percutaneous coronary intervention, and cardiovascular and overall mortality (5) (6) (7) (8) (9) . Recently, Schnabel et al. (10 ) demonstrated that ADMA is associated with the primary end points of cardiovascular death and myocardial infarction, whereas they observed no relationship with death from causes other than cardiovascular disease. In the Coronary Artery Risk Development in Young Adults (CARDIA) Study among white and black young adult men and women, ADMA was independently associated with the presence of coronary artery calcification, a marker of arteriosclerotic burden (11 ) .
Interestingly, ADMA provided independent predictive power even after adjustment for other more recent markers, i.e., B-type natriuretic peptide and highsensitivity C-reactive protein (hsCRP), which have increasingly been a routine part of clinical assessment (10 ) .
In recent years, several analytical methods have been developed to determine ADMA concentrations, such as HPLC (12 ) , capillary electrophoresis (13 ) , mass spectrometry-based methods (14 ) , and a recently developed ELISA (15 ) . Schulze et al. (16 ) defined a reference interval for ADMA plasma concentrations of 0.36 -1.17 mol/L in 500 healthy white individuals 19 to 75 years old using ADMA ELISA techniques. Because the majority of studies investigating the role of ADMA with regard to cardiovascular disease have been performed in European cohorts, there is limited information regarding the distribution of ADMA concentrations among individuals with different ethnicities (11, 17, 18 ) . Therefore, we performed a crosssectional study in 980 older, healthy individuals with different ethnicities living in the San Francisco Bay area and analyzed ADMA plasma concentrations and their relationship to other cardiovascular risk factors.
Materials and Methods

SOURCE POPULATION AND STUDY DESIGN
Participants of the study were a representative sample of healthy Kaiser Permanente Health Plan members aged 60 -72 years at time of survey living in the San Francisco Bay area. The participants were originally recruited as a control group for a genetic association study, which dictated the relatively narrow age range; the present study was a secondary goal of the research. The age range for this control group was chosen to reduce the likelihood of including those with the potential for imminent cardiovascular diagnosis. The institutional review boards of Kaiser Permanente Division of Research and Stanford University approved the study, and all participants gave written informed consent.
All participants were asked about past history of hyperlipidemia, hypertension, diabetes, parental and sibling history of arteriosclerotic disease, tobacco, and current medication use. We defined hypertension as self-report of hypertension or systolic blood pressure Ն140 mmHg, diastolic blood pressure Ն90 mmHg, or use of antihypertensive medication. We defined diabetes as self-report of diabetes, fasting blood glucose Ն1260 mg/L, use of antidiabetic medication. Hormone replacement therapy and use of cholesterol-lowering medication were ascertained by self-report.
We determined ancestry from self-report of birthplace, race, and ethnicity for the participant and his or her 4 grandparents. If self-reported race and ethnicity and all grandparents' race and ethnicity were concordant, the individuals were coded to that race and ethnicity category (80% of individuals met these criteria). For discordant cases, the assigned race variable was reviewed by a committee and assigned based on grandparents' ethnicity. A person of mixed race/ethnicity with a Hispanic component was considered "mixed Hispanic"; otherwise he or she was considered "mixed non-Hispanic."
We measured height and weight with a stadiometer and balance scale with heavy clothing and shoes removed and calculated body mass index (BMI) as weight/height 2 (kg/m 2 ). We measured waist circumference without outer clothing at end-expiration to the nearest 0.1 cm, in duplicate, using a Gulick II 150-cm weighted anthropometric tape measure (model 67021) at a point midway between the iliac crest and the lowest lateral portion of the rib cage (the natural waist). We used the Framingham coronary prediction algorithm to estimate the total coronary heart disease risk (risk of developing 1 of the following: angina pectoris, myocardial infarction, or coronary disease death) over the course of 10 years. This calculation includes sex, age, blood total and HDL cholesterol concentration, systolic blood pressure, cigarette smoking, and diabetes (19 ) .
Blood samples were drawn after an overnight fast and stored at Ϫ80°C until analysis. The protocols for lipid determination can be found elsewhere (20 -22 ) . Fasting glucose and insulin were analyzed by the Diabetes Research and Training Center at Washington University in St. Louis using the hexokinase-ultraviolet method and a RIA, respectively. We measured cystatin-C using a particle-enhanced immunonephelometric assay (N Latex cystatin-C; Dade Behring) with a nephelometer BNII (Dade Behring). We calculated the cystatin-C-based estimated glomerular filtration rate [ 
ADMA MEASUREMENT
We measured plasma ADMA concentrations using a recently developed, highly sensitive ELISA kit (DLD Diagnostika GmbH) (15 ) . The intensity of the developing color is inversely proportional to the amount of ADMA in the sample and measured by reading the absorbance at 450 nm using a microtiter plate reader (Tecan GENios). This ELISA assay has been validated against liquid chromatography-tandem mass spectrometry (n ϭ 29; r ϭ 0.98; P Ͻ 0.0001) (15 ) . All plasma ADMA measurements were performed by a single individual, who was blinded to status of the participants. We measured each sample in duplicate and used the average of the 2 measurements for further analyses.
STATISTICAL ANALYSIS
All data are given as mean (SD), unless otherwise indicated. For nonparametric comparison of 2 groups, we used the Mann-Whitney U-test. We tested correlation using the Spearman correlation coefficient and assessed nonparametric comparison of more than 2 groups by Kruskal-Wallis test. We performed multivariate regression models examining the relationship of ADMA and cardiovascular risk factors and biomarkers using backward stepwise elimination analysis. Because of the nonnormal distribution of ADMA as determined by using the Kolmogorov-Smirnov test, ADMA was log-transformed for regression analyses. All tests were performed with SAS software version 9.1. To calculate the reference interval, we used the nonparametric, rank-based method published in the approved recommendation on reference values of the IFCC (24 ) . We compared the distribution of ADMA concentrations across quintiles of cystatin-C using the Kruskal-Wallis test. A 2-tailed P Ͻ 0.05 was accepted as the level of statistical significance.
Results
DEMOGRAPHIC AND ANTHROPOMETRIC CHARACTERISTICS OF THE STUDY SAMPLE
ADMA was measured in 980 study participants with a mean age of 65.8 (2.9) years; the sample included 617 (63.0%) men and 363 (37.0%) women. The clinical characteristics of the study sample are listed in Table 1 BSA] estimated for the entire sample and separated into men and women indicated a mild decrease in kidney function according to the National Kidney Foundation classification (Table 1 ) (25 ) . A few individuals were current smokers (7.8%), whereas most were either nonsmokers (40.9%) or had quit smoking in the past (59.1%). Self-reported race and ancestry data indicated that 67.5% (n ϭ 661) of the participants were white, 8.4% (n ϭ 82) African-American, 5.5% (n ϭ 54) Hispanic, 1.1% (n ϭ 11) South Asian, 6.8% (n ϭ 67) East Asian, 7.6% (n ϭ 74) mixed non-Hispanic, and 3.2% (n ϭ 31) mixed Hispanic.
Compared with men, women had higher total and HDL cholesterol, hsCRP concentration, Framingham risk score (P Ͻ 0.05), and eGFR CysC and lower diastolic blood pressure, triglycerides (P Ͻ 0.05), fasting glucose, cystatin-C concentration (P Ͻ 0.05), waist circumference, eGFR CoCysC , and prevalence of diabetes (all others P Ͻ 0.01; Table 1 ).
ADMA CONCENTRATIONS
The mean ADMA concentration of the entire sample In the entire sample, ADMA was positively correlated with age ( ϭ 0.08, P Ͻ 0.01), BMI ( ϭ 0.10, P Ͻ 0.01), waist circumference ( ϭ 0.10, P Ͻ 0.01), cystatin-C and eGFR CysC (each ϭ 0.32, P Ͻ 0.01), and eGFR CoCysC ( ϭ 0.33, P Ͻ 0.01). In men, ADMA was positively correlated with age ( ϭ 0.09, P Ͻ 0.05), waist circumference ( ϭ 0.10, P Ͻ 0.02), cystatin-C and eGFR CysC (each ϭ 0.29, P Ͻ 0.01), and eGFR CoCysC ( ϭ 0.30, P Ͻ 0.01). In women, ADMA was inversely correlated with HDL cholesterol ( ϭ Ϫ0.19, P Ͻ 0.01) and positively correlated with total cholesterol/HDL ratio ( ϭ 0.15, P Ͻ 0.01), BMI ( ϭ 0.16, P Ͻ 0.01), waist circumference ( ϭ 0.14, P Ͻ 0.01), and cystatin-C, eGFR CysC , and eGFR CoCysC (each ϭ 0.37, P Ͻ 0.001).
We performed multivariate regression models examining the relationship of ADMA and cardiovascular risk factors and biomarkers using a backward stepwise elimination analysis. In men, cystatin-C (partial R 2 ϭ 0.093; P Ͻ 0.0001), fasting glucose (partial R 2 ϭ 0.010; P ϭ 0.01), and HDL cholesterol (partial R 2 ϭ 0.008; P Ͻ 0.05) remained as independent variables in the model after stepwise backward elimination analysis. In women, cystatin-C (partial R 2 ϭ 0.165; P Ͻ 0.0001), CRP (partial R 2 ϭ 0.023; P Ͻ 0.01), and fasting insulin (partial R 2 ϭ 0.012; P Ͻ 0.05) remained as independent variables in the model after stepwise backward elimination analysis (Table 3) .
ADMA CONCENTRATION AND ETHNICITY
The distributions of the ADMA concentrations by ethnicity and sex are shown in Table 2 . Analysis revealed a significantly lower mean ADMA concentration in the overall African-American and mixed non-Hispanic subjects compared with white subjects by Dunnett's 2-sided post hoc test. Comparing African-American and white men, the difference in ADMA concentrations remained significant even after adjustment for fasting glucose and cystatin-C (African Americans vs whites, 0.60 vs 0.65 mol; P Ͻ 0.01). Multivariate anal- yses were not done in women because of the small sample size.
ADMA AND CARDIOVASCULAR RISK FACTOR ASSOCIATIONS
Analyses of clinical factors by ethnicity indicated a significant correlation of ADMA concentrations with age, total and HDL cholesterol, BMI, and waist circumference only in whites (Table 4) . Cystatin-C correlated with ADMA levels in whites and mixed non-Hispanics.
CRP was positively correlated with ADMA in mixed Hispanics but not in other race groups. No significant correlations between ADMA and cardiovascular risk factors were found for African-American, Hispanic, South Asian, and East Asian ethnicities (Table 4) . Spearman correlations between ADMA concentrations and cystatin-C for the entire sample were ϭ 0.32 (n ϭ 980; P Ͻ 0.001), for men ϭ 0.29 (n ϭ 617; P Ͻ 0.001), and for women ϭ 0.37 (n ϭ 363; P Ͻ 
Discussion
Over the past decade, asymmetric dimethylarginine has emerged as a novel cardiovascular risk factor. Recently, Schulze et al. (16 ) determined reference values for ADMA in 500 healthy white men and women over a wide age range. However, no information is currently available regarding the distribution of ADMA concentrations among healthy, older individuals of different ethnicities.
The incidence and prevalence of cardiovascular disease differ among some racial and ethnic groups in the US. African Americans tend to have higher cardiovascular disease rates than do whites, particularly among women (26 ) . Hispanic populations in the US tend to have lower rates of cardiovascular disease and overall mortality compared to the general population, despite high risk factor levels, although data are not consistent in this regard (27, 28 ) . East Asians (particularly Chinese Americans, Japanese Americans, and immigrants from Southeast Asia) have lower morbidity and mortality rates than whites (29 ) .
Demographic and anthropometric data in our overall study sample showed distributions that were similar to other large-scale epidemiologic studies. The ADMA central 95% reference interval in our overall sample was 0.47 (90% CI 0.46 -0.48) to 0.85 (90% CI 0.84 -0.89) mol/L. The mean ADMA concentration in our sample was slightly lower than that found in the European study by Schulze et al. (16 ) (0.63 mol/L compared with 0.69 mol/L) using the same ADMA ELISA techniques. In contrast to Schulze et al. (16 ) , we did not see a significant sex difference in ADMA concentrations in this larger sample of healthy older individuals. ADMA concentrations were significantly lower in African Americans and mixed non-Hispanics compared with whites. These results are consistent with prior data from the CARDIA study indicating lower ADMA concentrations among young adult African-American men and women relative to white men (11 ) . In a recently published study, Melikian et al. (17 ) reported higher ADMA serum concentrations in black Africans compared with white Europeans (0.34 vs 0.25 mol/L). Of note, these values were obtained from a small study population (n ϭ 30 black Africans and n ϭ 28 whites) and were generally much lower than the present study and other studies using the same ADMA ELISA techniques (10, 11, 16 ) .
We confirmed a positive correlation between ADMA and BMI, waist circumference, and age in the overall sample. Determination of BMI and waist circumference are useful measures in the evaluation of insulin resistance (30 ) . In this regard, it is intriguing that insulin resistance is associated with increased ADMA concentrations (31, 32 ) . In addition, plasma ADMA concentrations are increased in patients with type 2 diabetes and are associated with the impairment of insulin-mediated glucose disposal in nondiabetic normotensive subjects (31, 33 ) .
Furthermore, we found a positive correlation between ADMA and cystatin-C in this population. Kidney function is a risk factor for mortality in the elderly (34 ) . Plasma creatinine concentrations or creatininebased estimators of glomerular filtration rate are the standard measures of kidney function in clinical practice and research and are generally thought to reflect 24-h clearance rates. Cystatin-C is a promising new measure of kidney function that has been found to better predict GFR than creatinine. Cystatin-C may have a particular advantage in the elderly, as the concentrations do not seem to be influenced by age, sex, or muscle mass (35 ) . In prospective studies, cystatin-C showed a stronger linear association with mortality risk than creatinine or creatinine-based estimates of GFR (36 ) , and quintiles of cystatin-C were able to define low, medium, and high mortality risk (36, 37 ) .
We observed a strong correlation of cystatin-C with ADMA. This correlation was observed for the entire sample, but also when analyzed by sex, with the strength of the correlation being strongest in women. Interestingly, mean plasma ADMA concentrations increased with cystatin-C quintiles in the entire study sample. Several studies have demonstrated that con- A strong relation between serum creatinine and the risk for cardiovascular complications after a myocardial infarction has been recently described by Anavekar et al. (40 ) . We did not measure serum creatinine concentrations in the present study. To exclude the possibility that ADMA measurement is simply mirroring renal function, Schnabel et al. (10 ) introduced glomerular filtration rate in all regression models of their study. The results of their study supported the notion that ADMA provides additional risk information that is, at least in part, independent of renal func- tion. Although our present study is cross-sectional in nature, our findings may provide relevant information regarding the relationships between ADMA, renal dysfunction, and coronary artery disease. A recent study by Kovesdy et al. (41 ) in 1243 outpatients found that, in the later stages of chronic kidney disease but before dialysis is needed, black patients are less likely to die than whites. The age of the cohort in the study of Kovesdy et al. was 68 (11) years, and 24% of participants were black, with an average eGFR of 37 mL/min/ 1.73m 2 . As we know from a recent review by Kielstein and Zoccali (42 ) , ADMA concentrations are able to predict mortality in patients with chronic kidney disease. Considering these observations, our present study may offer an explanation for the finding of Kovesdy et al. (41 ) and opens the possibility that increased ADMA may play a role in the causal pathway between renal dysfunction and coronary artery disease (43 ) .
In agreement with the study by Schnabel et al. (10 ), we were not able to show correlations of ADMA with total and LDL cholesterol or triglyceride concentrations, which have been described by others (44 ) . However, we were able to detect a correlation of ADMA and total and HDL cholesterol concentrations in whites. Moreover, we found that ADMA was correlated with HDL cholesterol in women.
We were not able to find significant correlations between ADMA and other variables in several of the ancestry subgroups; however, this lack of significance may reflect our smaller sample sizes in these ethnic groups. For example, the correlation between ADMA and cystatin-C is very similar in the mixed Hispanic group compared with the white group, but the P value is higher. The same trend can be observed in some but not all other subgroups. Our power in these subgroups is low, so the lack of significance may be a false-negative finding, and represents a potential limitation of our study. An additional limitation of our study is that the age range of our population cohort is narrow, and future studies investigating the relationship between ADMA and ethnicities should include individuals with a broader age range.
In accord with the studies by Schulze et al. (16 ) and Schnabel et al. (10 ) , we used the recently developed ADMA ELISA (15 ) , which represents a wellvalidated method that is suitable for the determination of ADMA in large sample series. Therefore, the measured ADMA concentrations and the determined reference values for healthy, older individuals of different ethnicities of the present study are comparable to those of other large-scale ADMA studies.
In conclusion, we were successful in defining reference intervals for ADMA plasma concentrations in a population of healthy, older individuals of different ethnicities. ADMA concentrations varied nearly 2-fold across our healthy sample of older men and women, correlated with age, BMI, and renal function, and were different across ethnic groups. Additional studies in a wider age range and with larger ethnic subgroups would be useful. 
